Global Cell Expansion
Market Report
2025
As per Cognitive Market Research's latest published report, the Global Cell Expansion market size was USD 16,011.5 Million in 2022. Cell Expansion Industry's Compound Annual Growth Rate will be 10.8% from 2023 to 2030.
The base year for the calculation is 2024. The historical will be 2021 to 2024. The year 2025 will be estimated one while the forecasted data will be from year 2025 to 2033. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Cell Expansion Market Report 2025.
According to cognitive market research, the global cell expansion market size was valued at USD xx billion in 2024 and is expected to reach USD xx billion at a CAGR of xx% during the forecast period.
2024 | 2025 | 2032 | 2033 | CAGR | |
---|---|---|---|---|---|
Global Cell Expansion Market Sales Revenue | 121212 | 121212 | 121212 | 121212 | 10.8% |
Base Year | 2024 |
Historical Data Time Period | 2021-2024 |
Forecast Period | 2025-2033 |
Market Split by Product |
|
Market Split by Cell Type |
|
Market Split by Application |
|
Market Split by End-User |
|
List of Competitors |
|
Regional Analysis |
|
Country Analysis |
|
Market Drivers:
| |
Market Restrains:
| |
Market Trends:
|
Report scope is customizable as we have a huge database of Cell Expansion industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Cell Expansion Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Cell expansion is the artificial production of large-scale daughter cells from an individual cell to support clinical research. Cell expansion controls the loosening of the wall and requires the synthesis of new cell wall material to enable it to increase and stretch in the area. Cell expansion is utilized in life science and is associated with drug development, drug screening, and research and development activities.
Cell expansion is the process in which a cell grows in size due to a multitude of mechanisms, including nutrition intake protein or organelle production, and waste product accumulation. This plays a significant role in organismal development, tissue repair, and regeneration. Cell expansion is powered by the cell’s internal machinery, which produces the energy and materials required for growth. It is controlled by several hormones and growth factors that determine the pace of cell expansion.
Cell expansion is used to create novel drugs to treat illnesses. It is used to make vaccinations, medications, therapies, and antibiotics. Due to the rising incidence of diseases like cancer and diabetes, there is an urgent need for in-depth research to produce novel treatment options. Chronic diseases are long-term illnesses that are frequently incurable, however, they are sometimes treatable and manageable. Chronic disease rates are rising as a result of increased tobacco consumption, poor diet, physical inactivity, excessive alcohol consumption, and other factors. By 2045, the number of individuals with diabetes is expected to increase from an estimated 425 million in 2017 to 629 million, according to the International Diabetes Federation (IDF).
(Source:https://idf.org/about-diabetes/diabetes-facts-figures/ )
Advanced technologies such as perfusion culture systems, microcarrier-based systems, and single-use bioreactors are playing an important role in surging the efficiency of cell growth processes and enabling the development of a large number of cells while retaining favorable features. Technological advancements in automation and bioprocessing are driving the market of cell expansion, with vital implications for regenerative medicine and cell therapy. Innovative technologies like single-use bioreactors, microcarrier-based systems, and perfusion culture systems have played a pivotal role in enhancing the efficiency of cell expansion processes, ensuring the cultivation of a greater number of cells while maintaining desired characteristics. By reducing manual labor and minimizing variability, automated systems contribute to consistent product quality. The integration of robotics and artificial intelligence further advances manufacturing timelines and enhances safety and compliance in bioprocessing.
• For instance, In March 2024, CellRev, in partnership with Getinge, launched a breakthrough adherent cell expansion platform, Livit ACE. Designed to eliminate many of the limitations and inefficiencies associated with adherent cell culture, Livit ACE reduces costs, enhances productivity, and accelerates development times.
(Source:https://www.einpresswire.com/article/698451490/cellrev-in-partnership-with-getinge-launches-a-breakthrough-adherent-cell-expansion-platform-livit-ace )
• For instance, in January 2021, Thermo Fisher Scientific introduced the Gibco CTS OpTmizer Pro Serum Free Media platform for developing and expanding human T lymphocyte cell therapy developers using allogeneic workflows. This platform targets donor cell metabolism, making it suitable for allogeneic, off-the-shelf cell therapies.
(Source:https://www.pharmaceuticalcommerce.com/view/thermo-fisher-unveils-novel-medium-for-t-cell-expansion )
Since human and animal cells are employed in gene therapy trials involving gene recombination and stem cell therapies, both species must be used in cell biology research. These cells are also used to test the toxicity and pharmacokinetics of medicines that might be harmful to people and animals when administered in vivo. Human embryos are regularly murdered in stem cell research projects that employ them for medical purposes. Strict restrictions have been established by ethical authorities worldwide to control these activities. The use of embryonic stem cells is the major concern that creates ethical concerns about the disturbance of human embryos. This has led to challenges in using embryonic stem cells in various countries and restraining their availability for therapeutic and research. The sourcing of cells is another concern for Ethical. Adult stem cell extraction often includes invasive procedures and creates concerns about safety and patient consent due to offering an ethical alternative to embryonic stem cells.
Mesenchymal stromal cells (MSCs) offer an effective way to lessen the harmful effects of the COVID-19 infection. This therapy has been shown to enhance tissue repair and reduce the release of pro-inflammatory cytokines in COVID-19 patients. According to the WHO ICTRP and the NIH ClinicalTrials databases, 27 clinical investigations of MSC-based cell treatment methods have begun since the beginning of the COVID-19 epidemic in China, along with an expanding number of university and industrial trials abroad. Cell expansion is frequently employed in stem cell and regenerative medicine research. This is a crucial indicator of market growth because the COVID-19 study shows that stem cell-based medications have a wide range of potential applications. The COVID-19 research also makes use of a wide range of cell growth apparatus (such as bioreactors) and materials (such as cell culture media). As a result, the COVID-19 pandemic has been beneficial for the cell growth industry.
(Source:https://www.researchgate.net/publication/340690946_Cell-Based_Therapies_for_COVID-19_Proper_Clinical_Investigations_are_Essential )
Developing economies such as India, China, the U.S., Canada, and Japan are estimated to show potential growth opportunities for market players operating in the market enhanced by factors such as rising government support, expansion of market key players, rising technological advancements, growing biopharmaceutical sector expanding manufacturing capabilities and rising healthcare spendings. The major market players contribute to improving access to quality healthcare products and expanding their existence in developing countries across the world by adopting these opportunities. These are the major opportunities expected to accelerate the growth of the cell expansion market shortly.
We have various report editions of Cell Expansion Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Major market participants who are essential in determining consumer preferences and market dynamics have a major impact on the cell expansion market. These major players provide consumers with easy access to a vast array of wardrobe options through their extensive retail networks and online platforms. Product adoption has increased as a result of their strong worldwide presence and well-known brand, which has also increased consumer trust and loyalty. In addition, these industry titans never stop funding R&D, bringing cutting-edge styles, materials, and practical features to clothing wardrobes to meet changing customer demands and preferences. These big players’ combined efforts have a big impact on the market’s future direction and level of competition.
Top Companies Market Share in Cell Expansion Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
North America accounted for the largest revenue share of xx% in 2024. The region is anticipated to retain its leading position in the coming years due to a rise in funding initiatives by government agencies, which has accelerated the manufacturing of stem cells and the development of regenerative medicines and cellular therapy products. This, in turn, drives the demand for cell expansion platforms in this region. North America had the largest share in 2024 due to increased government funding initiatives that have accelerated the production of stem cells and the development of regenerative medicine and cellular therapy products, the region will continue to hold the top spot in the coming years. This drives up demand for cell expansion platforms even more in this region.
Asia Pacific is expected to witness the fastest CAGR of over xx% during the forecast period, due to increasing initiatives by several local pharmaceutical and biotechnology companies to develop and commercialize their cellular therapies. In September 2022, Alkem Laboratories, in collaboration with Stempeutics, launched the first off-the-shelf cell therapy product, "StemOne," for treating knee osteoarthritis in India. The product has received regulatory approval from the Drugs Controller General of India, making it the first allogeneic cell therapy product approved for commercial use in the country. In India, various well-developed biotechnology companies are improving or developing cell expansion.
The current report Scope analyzes Cell Expansion Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
Global Cell Expansion Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Cell Expansion Industry growth. Cell Expansion market has been segmented with the help of its Product, Cell Type Application, and others. Cell Expansion market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
Consumables led the product segment in 2024 and accounted for xx% of the overall market share. The segment is furthermore estimated to retain its dominant position throughout the forecast years. The availability of a wide range of commercial media and reagent products that are dedicated to specific types of cells contributes to the large revenue share of this segment. Consumables refer to products such as reagents, media, sera, and disposable bioreactor systems that are regularly used and replaced throughout the cell expansion. These materials are crucial for the maintenance and proliferation of cells in vitro. In addition, these products are convenient, ready to use, and are also available as serum-free formulations. Due to automation in bioreactors and other expansion platforms to increase the efficiency of culturing activities, the instruments segment is anticipated to experience the quickest growth throughout the forecast period.
• For instance, in May 2023, Lonza introduced TheraPEAK T-VIVO Cell Culture Medium, a chemically defined medium optimized for the manufacturing of CAR T-cells.
(Source:https://www.lonza.com/media-advisories/2023-05-16-14-00 )
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Cell Expansion Industry. Request a Free Sample PDF!
The mammalian cells segment held the highest revenue share in 2024 and is expected to remain dominant during the forecast period, as these culture systems are highly preferred in the production of complex protein therapeutics. This is because these systems are pharmacokinetically and functionally relevant to post-translational modifications in humans. Therefore, most of the biopharmaceuticals, including monoclonal antibodies, specific interferons, thrombolytics, and various therapeutic enzymes, are produced using these culture systems. Mammalian cell culture is an important tool for research, clinical, and pharmaceutical applications. Cells isolated from animal tissues can be expanded in culture to study cell biology and disease or used for the production of antibodies, proteins, and vaccines.
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
The biopharmaceutical segment captured the largest revenue share owing to an increase in the approval rate of biopharmaceutical products in the past few years. The entry of new biopharmaceutical companies and the proliferation of bioprocessing technologies further drive the development of biopharmaceuticals, which, in turn, boosts the expansion procedures conducted during bio-production. The development of biopharmaceuticals is further fueled by the entry of new biopharmaceutical businesses and the spread of bioprocessing technology, which in turn stimulates the methods used during bioproduction to expand. Moreover, single-use technologies are quickly taking over the commercial manufacture of cellular therapies.
The biotechnology & biopharmaceutical companies segment held the largest share of xx% in 2024 and is poised to expand further at a significant growth rate. The broadening horizon of cell-based therapeutics in the healthcare industry is one of the major factors contributing to the large share of biopharmaceutical companies. The expanding potential of cell-based medications in the healthcare industry is one of the primary reasons for the large proportion of biopharmaceutical enterprises. For instance, cellular-based therapies have gained immense popularity in regenerative medicines, with constant improvements in injectable cell delivery systems for various clinical applications.
• For instance, In March 2023, TrakCel and Lonza achieved a significant milestone through the combination of the former’s ‘OCELLOS’ cell orchestration platform with Lonza's manufacturing platform MODA-ES.
(Source:https://trakcel.com/news/trakcel-and-lonza-complete-integration-milestone/ )
• For instance, In April 2024, Amsbio, the biotechnology company, launched a developed GMP-complaint version of chemically defined and animal-origin-free StemFit iPSC expansion medium. This product is produced to improve the pluripotency and growth of induced stem cells. This product offered superior iPSC maintenance, expansion, and long-term genetic stability performance.
(Source:https://www.rapidmicrobiology.com/news/amsbio-launches-gmp-compliant-stemfit-ipsc-expansion-medium )
Senior Research Analyst at Cognitive Market Research
ResearchGate Profile: https://www.researchgate.net/profile/Kalyani-Raje
An optimistic Senior Research Analyst with years of experience in competitive assessment and business consulting. A seasoned professional and subject-matter expert (SME) in the Automobile and transportation vertical.
With a work experience of over 10+ years in the market research and strategy development. I have worked with diverse industries, including FMCG, IT, Telecom, Automotive, Electronics and many others. I also work closely with other departments such as sales, product development, and marketing to understand customer needs and preferences, and develop strategies to meet those needs.
I am committed to staying ahead in the rapidly evolving field of research and analysis. This involves regularly attending conferences, participating in webinars, and pursuing additional certifications to enhance my skill set. I played a crucial role in conducting market research and competitive analysis. I have a proven track record of distilling complex datasets into clear, concise reports that have guided key business initiatives. Collaborating closely with multidisciplinary teams, I contributed to the development of innovative solutions grounded in thorough research and analysis.
Cell expansion is the artificial production of large-scale daughter cells from an individual cell to support clinical research. Cell expansion controls the loosening of the wall and requires the synthesis of new cell wall material to enable it to increase and stretch in the area. The development of biopharmaceuticals is further fueled by the entry of new biopharmaceutical businesses and the spread of bioprocessing technology, which in turn stimulates the methods used during bioproduction to expand. Cell expansion has multiple potential applications, including drug testing and development, cell therapy development, and cancer tissue research.
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
• In January 2024, an Israel-based biotech company, Pluri, launched PluriCDMO, a new business division. This new division offered cell therapy manufacturing solutions as a manufacturing organization and contract development (CDMO). The advanced division involves a production facility of 47,000-ft2 good manufacturing practice cell therapy.
(Source:https://pluri-biotech.com/releases/pluri-launches-advanced-global-cell-therapy-contract-development-and-manufacturing-organization/ )
• In April 2022, STEMCELL Technologies Canada and Applied Cells Inc. joined forces to develop a modern way to separate cells, through the combination of the MARS platform of Applied Cells with STEMCELL's EasySep kits to make isolating cells from different samples easier and more automatic.
(Source:https://www.stemcell.com/applied-cells-enters-into-a-supply-agreement-with-stemcell.html )
• In March 2020, Danaher Corp. completed the purchase of General Electric Co.'s biopharma division for USD 21.4 billion. The company, which will go by the name Cytiva, will function autonomously within Danaher's biosciences division.
(Source:https://investors.danaher.com/2019-02-25-Danaher-to-Acquire-the-Biopharma-Business-of-General-Electric-Life-Sciences-for-21-4-Billion )
Disclaimer:
Product | Consumables, Culture Flasks and Accessories, Instruments |
Cell Type | Mammalian, Animal |
Application | Biopharmaceuticals, Tissue Culture & Engineering, Vaccine Production, Drug Development, Gene Therapy, Cancer Research, Stem Cell Research |
End-User | Biopharmaceutical & Biotechnology Companies, Research Institutes, Cell Banks |
List of Competitors | GE Healthcare Life Sciences, Thermo Fisher Scientific, Terumobct, Xpand Biotechnology, BINKIT, AMMSTM, Lonza Group, Terumo, Becton Dickinson |
This chapter will help you gain GLOBAL Market Analysis of Cell Expansion. Further deep in this chapter, you will be able to review Global Cell Expansion Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
This chapter will help you gain North America Market Analysis of Cell Expansion. Further deep in this chapter, you will be able to review North America Cell Expansion Market Split by various segments and Country Split.
Chapter 2 North America Market Analysis
This chapter will help you gain Europe Market Analysis of Cell Expansion. Further deep in this chapter, you will be able to review Europe Cell Expansion Market Split by various segments and Country Split.
Chapter 3 Europe Market Analysis
This chapter will help you gain Asia Pacific Market Analysis of Cell Expansion. Further deep in this chapter, you will be able to review Asia Pacific Cell Expansion Market Split by various segments and Country Split.
Chapter 4 Asia Pacific Market Analysis
This chapter will help you gain South America Market Analysis of Cell Expansion. Further deep in this chapter, you will be able to review South America Cell Expansion Market Split by various segments and Country Split.
Chapter 5 South America Market Analysis
This chapter will help you gain Middle East and Africa Market Analysis of Cell Expansion. Further deep in this chapter, you will be able to review Middle East and Africa Cell Expansion Market Split by various segments and Country Split.
Chapter 6 Middle East and Africa Market Analysis
This chapter provides an in-depth analysis of the market share among key competitors of Cell Expansion. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 7 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 8 Qualitative Analysis (Subject to Data Availability)
Segmentation Product Analysis 2019 -2031, will provide market size split by Product. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 9 Market Split by Product Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Cell Type Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Application Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by End-User Analysis 2021 - 2033
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Cell Expansion market
Chapter 13 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Chapter 14 Research Methodology and Sources
Why Consumables have a significant impact on Cell Expansion market? |
What are the key factors affecting the Consumables and Culture Flasks and Accessories of Cell Expansion Market? |
What is the CAGR/Growth Rate of Mammalian during the forecast period? |
By type, which segment accounted for largest share of the global Cell Expansion Market? |
Which region is expected to dominate the global Cell Expansion Market within the forecast period? |
Segmentation Level Customization |
|
Global level Data Customization |
|
Region level Data Customization |
|
Country level Data Customization |
|
Company Level |
|
Additional Data Analysis |
|
Additional Qualitative Data |
|
Additional Quantitative Data |
|
Service Level Customization |
|
Report Format Alteration |
|